Mianserin kinetics in depressed patients

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Psychopharmacology

Background:

• Mianserin is an antidepressant medication.
• Understanding drug kinetics is crucial for effective treatment.
• Variability in drug metabolism can impact therapeutic outcomes.

Purpose of the Study:

• To investigate the pharmacokinetic profile of mianserin.
• To compare mianserin kinetics with other antidepressant drugs.

Main Methods:

• Single 60 mg dose administration of mianserin to eight depressed inpatients.
• Measurement of plasma mianserin levels over time.
• Analysis of pharmacokinetic parameters including peak plasma levels, elimination half-life, first-pass loss, volume of distribution, and total body clearance.

Main Results:

• Considerable interpatient variability in plasma mianserin levels was observed.
• Mean peak plasma levels were 114 +/- 26 ng/ml, reached between 1-3 hours.
• The mean elimination half-life (t 1/2) was 21.6 +/- 3.1 hours.
• Estimated first-pass loss ranged from 26% to 48% (mean 37%).
• Mean apparent volume of distribution was 15.7 +/- 2.2 l/kg.
• Apparent total body clearance ranged from 0.33 to 0.81 l/hr/kg (mean 0.52 +/- 0.05 l/hr/kg).

Conclusions:

• Mianserin exhibits significant interpatient variability in its pharmacokinetic parameters.
• Mianserin's kinetics are generally similar to tertiary amine tricyclic antidepressants (e.g., imipramine) and the tetracyclic maprotiline.
• These findings contribute to understanding mianserin's behavior in the body and its comparison to other antidepressants.